Mark Walters, MO

NPI: 1588753610
Total Payments
$62,769
2024 Payments
$19,464
Companies
8
Transactions
42

Payment Breakdown by Category

Consulting$44,997 (71.7%)
Travel$11,241 (17.9%)
Other$5,300 (8.4%)
Food & Beverage$1,231 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $44,997 10 71.7%
Travel and Lodging $11,241 12 17.9%
Honoraria $4,700 1 7.5%
Food and Beverage $1,231 18 2.0%
Grant $600.00 1 1.0%

Top Paying Companies

Company Total Records Latest Year
VERTEX PHARMACEUTICALS INCORPORATED $39,363 17 $0 (2024)
SANOFI US SERVICES INC. $9,282 5 $0 (2023)
CSL Behring $5,919 5 $0 (2019)
Spark Therapeutics, Inc. $4,350 1 $0 (2020)
Celgene Corporation $2,116 3 $0 (2018)
BIOVERATIV THERAPEUTICS INC. $1,076 9 $0 (2019)
Novartis Pharmaceuticals Corporation $600.00 1 $0 (2020)
bluebird bio, Inc. $62.80 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $19,464 9 VERTEX PHARMACEUTICALS INCORPORATED ($19,464)
2023 $16,643 10 SANOFI US SERVICES INC. ($9,282)
2022 $5,670 2 Vertex Pharmaceuticals Incorporated ($5,670)
2021 $6,930 2 Vertex Pharmaceuticals Incorporated ($6,930)
2020 $4,950 2 Spark Therapeutics, Inc. ($4,350)
2019 $6,128 8 CSL Behring ($5,919)
2018 $2,925 8 Celgene Corporation ($2,116)
2017 $58.33 1 Bioverativ Therapeutics Inc. ($58.33)

All Payment Transactions

42 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/10/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $29.40 General
07/30/2024 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $7,568.30 General
07/30/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $2,520.02 General
07/30/2024 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $700.00 General
07/30/2024 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $120.48 General
07/30/2024 VERTEX PHARMACEUTICALS INCORPORATED Food and Beverage In-kind items and services $120.20 General
05/08/2024 VERTEX PHARMACEUTICALS INCORPORATED Consulting Fee Cash or cash equivalent $8,190.00 General
01/30/2024 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $185.63 General
01/30/2024 VERTEX PHARMACEUTICALS INCORPORATED Travel and Lodging In-kind items and services $30.00 General
12/09/2023 Vertex Pharmaceuticals Incorporated Food and Beverage In-kind items and services $6.17 General
12/08/2023 Vertex Pharmaceuticals Incorporated Food and Beverage In-kind items and services $38.81 General
12/06/2023 Vertex Pharmaceuticals Incorporated Food and Beverage In-kind items and services $8.93 General
09/12/2023 SANOFI US SERVICES INC. Consulting Fee Cash or cash equivalent $8,112.00 General
09/12/2023 SANOFI US SERVICES INC. Travel and Lodging In-kind items and services $667.66 General
09/12/2023 SANOFI US SERVICES INC. Travel and Lodging In-kind items and services $234.57 General
09/12/2023 SANOFI US SERVICES INC. Travel and Lodging Cash or cash equivalent $215.26 General
09/12/2023 SANOFI US SERVICES INC. Food and Beverage In-kind items and services $52.14 General
05/24/2023 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $7,245.00 General
03/15/2023 bluebird bio, Inc. Zynteglo (Drug) Food and Beverage In-kind items and services $62.80 General
Category: beta-thalassemia
07/27/2022 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $2,835.00 General
02/09/2022 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $2,835.00 General
09/02/2021 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $3,465.00 General
03/17/2021 Vertex Pharmaceuticals Incorporated Consulting Fee Cash or cash equivalent $3,465.00 General
08/01/2020 Novartis Pharmaceuticals Corporation Grant In-kind items and services $600.00 General
04/20/2020 Spark Therapeutics, Inc. Consulting Fee Cash or cash equivalent $4,350.00 General

About Mark Walters, MO

Mark Walters, MO is a Pediatric Hematology-Oncology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588753610.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Walters, MO has received a total of $62,769 in payments from pharmaceutical and medical device companies, with $19,464 received in 2024. These payments were reported across 42 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($44,997).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Location Oakland, CA
  • Active Since 10/12/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1588753610

Products in Payments

  • Luspatercept (Drug) $2,116
  • Alprolix (Drug) $492.90
  • Eloctate (Drug) $375.14
  • NO PRODUCT DISCUSSED (Drug) $208.42
  • Zynteglo (Drug) $62.80

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Oakland